InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,828.00
(
0.95%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.78
(
0.00%
)
Bitcoin
58,074.88
(
2.53%
)
Post# of 364542
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

nlightn

Send PM Follow Ignore
Followers 137
Posts 41656
Boards Moderated 7
Alias Born 01/05/2004

nlightn

Re: nlightn post# 216726

Monday, 10/13/2014 10:59:35 PM

Monday, October 13, 2014 10:59:35 PM

Post# of 364542
$AVNR,...Avanir presents AVP-923 Phase 2 data at neurology meeting

As previously reported, Avanir Pharmaceuticals (AVNR +2.4%) presented data from its Phase 2 clinical trial evaluating AVP-923 for the treatment of agitation in patients with Alzheimer's disease at a poster session today at the American Neurological Association Meeting.

invest at your own risk, based on your own due diligence, at your own risk tolerance

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up